SCHEMBL8629010

SCHEMBL8629010

O=[C]CCCCCN1C(=O)CCC1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 2/20 0.42
MGLL Q99685 2/20 0.42
SMN1; SMN2 Q16637 3/20 0.40
HPGD P15428 3/20 0.40
HTT P42858 2/20 0.40
POLB P06746 2/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
ALDH1A1 P00352 3/20 0.39
CHRM2 P08172 2/20 0.37
CHRM4 P08173 2/20 0.37
CHRM5 P08912 2/20 0.37
CHRM1 P11229 2/20 0.37
CHRM3 P20309 2/20 0.37
LMNA P02545 2/20 0.37
RAB9A P51151 2/20 0.37
MAPT P10636 2/20 0.37
HSP90AA1 P07900 1/20 0.37
TLR9 Q9NR96 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL34663 0.87 CHRM2 (0.42) FAAHMGLLHTTPOLBMEN1
SCHEMBL8632299 0.84 MGLL (0.52) FAAHMGLLSMN1; SMN2HPGDHTT
SCHEMBL8629340 0.84 MGLL (0.52) FAAHMGLLSMN1; SMN2HPGDHTT
SCHEMBL1982535 0.84 MGLL (0.52) FAAHMGLLSMN1; SMN2HPGDHTT
SCHEMBL8626070 0.84 MGLL (0.52) FAAHMGLLSMN1; SMN2HPGDHTT
SCHEMBL8829438 0.84 MGLL (0.52) FAAHMGLLSMN1; SMN2HPGDHTT
SCHEMBL8862703 0.84 MGLL (0.52) FAAHMGLLSMN1; SMN2HPGDHTT
SCHEMBL19233361 0.84 MGLL (0.52) FAAHMGLLSMN1; SMN2HPGDHTT
SCHEMBL8829446 0.82 FAAH (0.53) FAAHMGLLSMN1; SMN2HPGDHTT
SCHEMBL888672 0.77 MEN1 (0.50) FAAHMGLLSMN1; SMN2HPGDHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0329994-B1 Immunogen and its use in preparing antibodies to haemoglobin A1C BOEHRINGER MANNHEIM GMBH (DE) 1993-12-29 EP claimed
CN-117580593-A Anthracycline antibody conjugates 思进公司 2024-02-20 CN disclosed
CN-116847886-A Immunostimulatory compounds and conjugates 思进公司 2023-10-03 CN disclosed
CN-116829551-A Immunomodulatory antibody drug conjugates 思进公司 2023-09-29 CN disclosed
CN-115955980-A Variable charge joint 思进公司 2023-04-11 CN disclosed
US-5849863-A Cytolytic bradykinin antagonists UNIVERSITY OF COLORADO (US) 1998-12-15 US disclosed
EP-0848718-A1 CYTOLYTIC BRADYKININ ANTAGONISTS CORTECH, INC. (US) 1998-06-24 EP disclosed
US-5635593-A TWO OR MORE BRADYKININ ANTAGONIST PEPTIDES CHEMICALLY LINKED BY ONE OR MORE SUCCINIMIDO GROUP VIA THIOETHER BOND TO FORM DIMER OR HIGHER OLIGOMER CORTECH, INC. (US) 1997-06-03 US disclosed
US-5620958-A DIMERIZED PEPTIDES HAVING A BISSUCCINIMIDO GROUP ATTACHED TO CYSTEINE THIO GROUP; ANALGESICS FOR SEVERE PAIN CORETECH, INC. (US) 1997-04-15 US disclosed
WO-1997009347-A1 CYTOLYTIC BRADYKININ ANTAGONISTS CORTECH, INC. (US) 1997-03-13 WO disclosed
EP-0586613-A4 BRADYKININ ANTAGONISTS CORTECH INC (US) 1994-08-24 EP disclosed
EP-0586613-A1 BRADYKININ ANTAGONISTS CORTECH, INC. (US) 1994-03-16 EP disclosed
WO-1992017201-A1 BRADYKININ ANTAGONISTS CORTECH, INC. (US) 1992-10-15 WO disclosed
EP-0329994-A1 Immunogen and its use in preparing antibodies to haemoglobin A1C Roche Diagnostics GmbH (DE) 1989-08-30 EP disclosed